TITLE

Variant Angina Associated With Bitter Orange in a Dietary Supplement

AUTHOR(S)
Gange, Christopher A.; Madias, Christopher; Felix-Getzik, Erika M.; Weintraub, Andrew R.; Estes III, N. A. Mark
PUB. DATE
April 2006
SOURCE
Mayo Clinic Proceedings;Apr2006, Vol. 81 Issue 4, p545
SOURCE TYPE
Academic Journal
DOC. TYPE
Report
ABSTRACT
The Food and Drug Administration has banned the sale of ephedrine-based weight-loss products because of their association with many cardiovascular adverse effects. Bitter orange is now being used as a stimulant in "ephedra-free" weight-loss supplements but was recently implicated in adverse cardiovascular sequelae. To our knowledge, this report describes the first case of variant angina associated with bitter orange in a dietary supplement.
ACCESSION #
20449859

 

Related Articles

  • FDA to ban ephedra.  // National Petroleum News;Feb2004, Vol. 96 Issue 2, p11 

    Reports on the intention of the U.S. Food and Drug Administration to ban products containing ephedra. Issuance of a consumer alert on the safety of the products that are sold as dietary supplements; Intention of the agency to publish a final rule stating that the supplements containing...

  • Herbal phen/fen.  // Healthy Weight Journal;Sep/Oct97, Vol. 11 Issue 5, p86 

    Reports that the US Food and Drug Administration has received complaints regarding ephedrine, which is an ingredient in the Herbal Phen/Fen weight loss food supplement marketed by Nutri/System. Chinese medicinal herb used to treat asthma and Saint Johnswort.

  • FDA targets miracle weight loss claims. Devaney, Tim // Hill;11/4/2014, Vol. 21 Issue 110, p17 

    The article reports that the U.S. Food and Drug Administration (FDA) issues new guidelines for the manufacturers of dietary supplements, in an effort to tamp down on misleading weight loss claims.

  • Dietary Supplements: Uncertainties in Analyses Underlying FDA's Proposed Rule on Ephedrine Alkaloids: HEHS/GGD-99-90. Scanlon, William J.; Stevens, L. Nye // GAO Reports;7/2/1999, p1 

    Explores uncertainties in analyses underlying the United States Food and Drug Administration's (FDA) proposed rule on ephedrine alkaloids. Adverse events associated with ephedrine alkaloids; Scientific basis for FDA's proposed rule; Compliance of FDA with the requirements in the Regulatory...

  • Diet supplements face weighty questions. Clute, Mitchell // Natural Foods Merchandiser;Jun2008, Vol. 29 Issue 6, p15 

    The article reports on the implications of the petition filed by GlaxoSmithKline with the Food and Drug Administration (FDA) asking the agency to treat dietary supplements' weight loss claims as disease claims for dietary supplements in the U.S. The petition was criticized by supplements...

  • DIETARY WEIGHT-LOSS SUPPLEMENTS. Brown, Lisa S.; Churchilll, Sarah // Today's Dietitian;Jun2014, Vol. 16 Issue 6, p44 

    No abstract available.

  • Consumer Reports Names 12 Dietary Supplements - From Aristolochia to Yohimbe - Too Dangerous for the Marketplace.  // Ascribe Newswire: Medicine;4/6/2004, p48 

    In the May 2004 issue, "Consumer Reports," identifies 12 dietary supplements that are too dangerous to be on the market according to government warnings, adverse-event reports, and top experts. The potentially dangerous effects of most of these products have been known for more than a decade,...

  • Liver Injury in 12 Patients Taking the Herbal Weight Loss Aids Chaso or Onshido. Adachi, M.; Saito, H.; Kobayashi, H.; Hone, Y.; Kato, S.; Yoshioka, M.; Ishii, H. // Annals of Internal Medicine;9/16/2003, Vol. 139 Issue 6, pI47 

    Various herbal supplements are sold as weight loss aids. In many countries, including the United States, the authorities consider these products to be dietary supplements, not drugs. People can buy them without prescriptions, and the products are not subject to the same standards as drugs. In...

  • GlaxoSmithKline Petitions FDA to Disallow Weight Loss Claims for Dietary Supplements. Saxton, Kelly E. // HerbalGram;Aug-Oct2008, Issue 79, p66 

    The article reports that on April 17, 2008, GlaxoSmithKline (GSK), has filed a citizen petition to the Food and Drug Administration (FDA) to classify weight loss claims as disease claims. This would require all weight loss claims for dietary supplements to be pre-approved by the U.S. Food and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics